PDPeter Paul De Deyn

Peter Paul De Deyn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter Paul De Deyn has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex differences in parietal alpha power during sustained attention are related to conflict monitoring performance in mild cognitive impairment

    by Zhenyu Zhang, Stefanie Enriquez-Geppert, Peter P. De Deyn, Christoph S. Herrmann, Natasha M. Maurits, Branislava Ćurčić-Blake

    Background: Sex differences in cognition among individuals with dementias and prodromal stages such as amnestic mild cognitive impairment (aMCI) manifest in variations in severity and prevalence, but underlying brain activity patterns remain unclear. This study is a secondary endpoint study of the Cogmax project. Objective: We examined sex differences in parietal alpha power during an attention task (Simple Vigilance Task, SVT) and its association with conflict monitoring (Stroop Color-Word Test Part 3, T score) in individuals with aMCI. Methods: The SVT served as the EEG recording condition because of its low cognitive demands and visually driven structure, while the Stroop task provided an independent neuropsychological measure of conflict monitoring. Seventy-seven participants (23 females; 54 males) were included. We analyzed average power spectral density (PSD) across occipital and parietal electrodes (O1-Pz-O2-P7-P8) using multitaper Fourier transform. Normalized alpha power was calculated as integrated 7–11 Hz relative to total 0.1–40 Hz PSD. Results: All participants showed high accuracy on the SVT, indicating stable attentional engagement. Covariate-adjusted permutation tests, robust to unbalanced sample sizes, showed that females exhibited higher parietal alpha power and higher Stroop Part 3 T-scores than males. However, when Stroop performance was included as a covariate, the sex difference in alpha power became nonsignificant. A positive correlation between Stroop 3 scores and parietal alpha power was observed in females but not in males, suggesting a sex-specific relationship. Conclusions: Parietal alpha activity may be associated with conflict monitoring performance in aMCI, particularly among females, providing evidence for sex-related neural differences in aMCI.

  • Open Access

    Cognitive correlates of cortical thickness, white matter volume, and resting-state connectivity in mild cognitive impairment

    by Nido Dipo Wardana, Stefanie Enriquez-Geppert, Peter Paul De Deyn, Jan-Bernard C. Marsman, Fransje E. Reesink, André Aleman, Branislava Ćurčić-Blake

    Background: Individuals with mild cognitive impairment (MCI) are at an increased risk of developing Alzheimer's disease. Anatomical and functional brain alterations associated with this condition are still elusive. Objective: This study explored the cognitive correlates of cortical thickness, white matter (WM) volume, and resting-state connectivity among people with MCI. Methods: A total of 56 older participants (aged 51 to 92 years) with amnestic MCI were recruited. Cognitive abilities were measured using the Trail Making Task, the Stroop Color-Word Test, the Forward and Backward Digit Span test, and computerized n-back tasks. Morphometry was used to measure cortical thickness and WM volume from 3 T MR images, while functional connectivity was measured using resting-state fMRI and calculated using Independent Component Analysis. Voxel-wise regressions were used to test associations between cognitive scores and brain measures. Results: Worse working memory updating (n-back) performance was associated with lower cortical thickness of the left middle temporal gyrus. Additionally, at a lower demand, working memory performance was linked to frontoparietal network (FPN) intrinsic connectivity, while WM volume within the anterior segment of the left arcuate fasciculus and default mode network (DMN) resting-state connectivity were relevant when the demand was higher. Lower DMN connectivity was also associated with worse conflict monitoring (Stroop) performance (all cluster-corrected p s < 0.05). Conclusions: The findings highlight the relevance of the perisylvian region to working memory updating and conflict monitoring in people with MCI.

  • Open Access

    Coronary artery calcification reflects cognitive and cerebrovascular alterations in cognitively unimpaired adults

    by Sofia Marcolini, Jaime Mondragon, Johannes Castelein, Thomas W. Okell, Charlotte E. Teunissen, Inge M.W. Verberk, Anouk Hoorn, Rozemarijn Vliegenthart, Rudi A.J.O. Dierckx, Ronald J.H. Borra, et al.

    Coronary artery calcification (CAC) entails arterial wall hardening and lipid-rich plaques accumulation and may contribute to early cognitive decline. Its association with cognition, brain structure and function, Alzheimer’s disease, neurodegeneration, and inflammatory and lipid biomarkers remains unclear. We conducted a cross-sectional study of 278 cognitively unimpaired adults aged ≥ 50 years with absent (score = 0; n = 151) or high CAC (score ≥ 300; n = 127). Participants underwent cognitive testing, serum assays (Aβ42/40, pTau181, NfL, GFAP, inflammatory/lipid markers), and multimodal MRI (structural, resting-state and vessel encoded arterial spin labeling). High CAC was associated with lower general cognition, increased white matter hyperintensities, altered hippocampal and sensorimotor connectivity, and reduced perfusion in the inferior frontal gyrus pars opercularis. No group differences emerged in the serum biomarkers. These results reveal that high CAC is associated with cognitive and cerebrovascular changes independent of Alzheimer’s disease biomarker increase, suggesting vascular pathways in early brain aging.

  • Open Access

    Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease

    by Frank Jessen, Javier Arbizu, Mercé Boada, Mircea Balasa, Karim Bennys, Marina Boban, Katharina Bürger, Andrea Chincarini, Annachiara Cagnin, Peter Paul De Deyn, et al.

  • Open Access

    Copy Number Variation and Haplotype Analysis of 17q21.31 Reveals Increased Risk Associated with Progressive Supranuclear Palsy and Gene Expression Changes in Neuronal Cells

    by Hui Wang, Timothy S. Chang, Beth A. Dombroski, Po‐Liang Cheng, Ya‐Qin Si, Albert Tucci, Vishakha Patil, Leopoldo Valiente‐Banuet, Chong Li, Kurt Farrell, et al.

    Background: The 17q21.31 region with various structural forms characterized by the H1/H2 haplotypes and three large copy number variations (CNVs) represents the strongest risk locus in progressive supranuclear palsy (PSP).Objective: To investigate the association between CNVs and structural forms on 17q.21.31 with the risk of PSP.Methods: Utilizing whole genome sequencing data from 1684 PSP cases and 2392 controls, the three large CNVs (α, β, and γ) and structural forms within 17q21.31 were identified and analyzed for their association with PSP.Results: We found that the copy number of γ was associated with increased PSP risk (odds ratio [OR] = 1.10, P = 0.0018). From H1β1γ1 (OR = 1.21) and H1β2γ1 (OR = 1.24) to H1β1γ4 (OR = 1.57), structural forms of H1 with additional copies of γ displayed a higher risk for PSP. The frequency of the risk sub‐haplotype H1c rises from 1% in individuals with two γ copies to 88% in those with eight copies. Additionally, γ duplication up‐regulates expression of ARL17B, LRRC37A/LRRC37A2, and NSFP1, while down‐regulating KANSL1. Single‐nucleus RNA‐seq of the dorsolateral prefrontal cortex analysis reveals γ duplication primarily up‐regulates LRRC37A/LRRC37A2 in neuronal cells.Conclusions: The copy number of γ is associated with the risk of PSP after adjusting for H1/H2, indicating that the complex structure at 17q21.31 is an important consideration when evaluating the genetic risk of PSP. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.


  • Open Access

    Financial capability of people living with Parkinson’s disease – A case-control study

    by Akke-Marij D. Ariesen, Oliver Tucha, Dorien F. Bangma, Anselm B. M. Fuermaier, Josephien L. Jansen, Peter P. De Deyn, Janneke Koerts

    Parkinson's disease (PD) is a neurodegenerative disorder affecting 1% of people older than 60 years. One of the abilities that seems vulnerable to the cognitive impairments associated with PD is financial capability. This explorative study aimed to evaluate the extent and type of problems in financial capability of people with PD without a diagnosis of dementia. Participants were 31 people with PD and 62 matched controls. Participants completed an extensive test-battery, including measures for financial capability and cognitive functioning. Compared to controls, the PD-group performed significantly poorer on two financial competence tasks and showed a comparable performance on the other financial capability measures. For 45% of the PD-group, cognitive test performance was indicative of mild cognitive impairment, yet no significant difference was observed in overall cognitive functioning between the PD and control group. In the total sample, only small or medium correlations were found between financial competence and cognition, and between financial capability and the contextual factors of income and financial experience. The findings suggest that in the earlier stages of PD, when cognitive impairments are relatively mild, some problems may be observed in financial competence, yet other domains of financial capability appear less affected. The absence of strong correlations between financial competence and overall cognitive functioning indicates that standard neuropsychological assessments seem inadequate to make financial capability determinations. By offering insight into the financial capability of people in the milder stages of PD, the findings of the present study may aid in the development and provision of tailored support.


  • Open Access

    Noradrenaline release from the locus coeruleus shapes stress-induced hippocampal gene expression

    by Mattia Privitera, Lukas M von Ziegler, Amalia Floriou-Servou, Sian N Duss, Runzhong Zhang, Rebecca Waag, Sebastian Leimbacher, Oliver Sturman, Fabienne K Roessler, Annelies Heylen, et al.

    Exposure to an acute stressor triggers a complex cascade of neurochemical events in the brain. However, deciphering their individual impact on stress-induced molecular changes remains a major challenge. Here, we combine RNA sequencing with selective pharmacological, chemogenetic, and optogenetic manipulations to isolate the contribution of the locus coeruleus-noradrenaline (LC-NA) system to the acute stress response in mice. We reveal that NA release during stress exposure regulates a large and reproducible set of genes in the dorsal and ventral hippocampus via β-adrenergic receptors. For a smaller subset of these genes, we show that NA release triggered by LC stimulation is sufficient to mimic the stress-induced transcriptional response. We observe these effects in both sexes, and independent of the pattern and frequency of LC activation. Using a retrograde optogenetic approach, we demonstrate that hippocampus-projecting LC neurons directly regulate hippocampal gene expression. Overall, a highly selective set of astrocyte-enriched genes emerges as key targets of LC-NA activation, most prominently several subunits of protein phosphatase 1 (Ppp1r3c, Ppp1r3d, Ppp1r3g) and type II iodothyronine deiodinase (Dio2). These results highlight the importance of astrocytic energy metabolism and thyroid hormone signaling in LC-mediated hippocampal function and offer new molecular targets for understanding how NA impacts brain function in health and disease.


  • Open Access

    Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub-haplotypes

    by Hui Wang, Timothy S Chang, Beth A Dombroski, Po-Liang Cheng, Ya-Qin Si, Alberto Tucci, Vishakha Patil, Leopoldo Valiente-Banuet, Kurt Farrell, Catriona Mclean, et al.

    Importance: The chromosome 17q21.31 region, containing a 900 Kb inversion that defines H1 and H2 haplotypes, represents the strongest genetic risk locus in progressive supranuclear palsy (PSP). In addition to H1 and H2, various structural forms of 17q21.31, characterized by the copy number of α, β, and γ duplications, have been identified. However, the specific effect of each structural form on the risk of PSP has never been evaluated in a large cohort study. Objective: To assess the association of different structural forms of 17q.21.31, defined by the copy numbers of α, β, and γ duplications, with the risk of PSP and MAPT sub-haplotypes. Design, setting, and participants: Utilizing whole genome sequencing data of 1,684 (1,386 autopsy confirmed) individuals with PSP and 2,392 control subjects, a case-control study was conducted to investigate the association of copy numbers of α, β, and γ duplications and structural forms of 17q21.31 with the risk of PSP. All study subjects were selected from the Alzheimer’s Disease Sequencing Project (ADSP) Umbrella NG00067.v7. Data were analyzed between March 2022 and November 2023. Main outcomes and measures: The main outcomes were the risk (odds ratios [ORs]) for PSP with 95% CIs. Risks for PSP were evaluated by logistic regression models. Results: The copy numbers of α and β were associated with the risk of PSP only due to their correlation with H1 and H2, while the copy number of γ was independently associated with the increased risk of PSP. Each additional duplication of γ was associated with 1.10 (95% CI, 1.04-1.17; P = 0.0018) fold of increased risk of PSP when conditioning H1 and H2. For the H1 haplotype, addition γ duplications displayed a higher odds ratio for PSP: the odds ratio increases from 1.21 (95%CI 1.10-1.33, P = 5.47 × 10 -5 ) for H1β1γ1 to 1.29 (95%CI 1.16-1.43, P = 1.35 × 10 -6 ) for H1β1γ2, 1.45 (95%CI 1.27-1.65, P = 3.94 × 10 -8 ) for H1β1γ3, and 1.57 (95%CI 1.10-2.26, P = 1.35 × 10 -2 ) for H1β1γ4. Moreover, H1β1γ3 is in linkage disequilibrium with H1c (R 2 = 0.31), a widely recognized MAPT sub-haplotype associated with increased risk of PSP. The proportion of MAPT sub-haplotypes associated with increased risk of PSP (i.e., H1c, H1d, H1g, H1o, and H1h) increased from 34% in H1β1γ1 to 77% in H1β1γ4. Conclusions and relevance: This study revealed that the copy number of γ was associated with the risk of PSP independently from H1 and H2. The H1 haplotype with more γ duplications showed a higher odds ratio for PSP and were associated with MAPT sub-haplotypes with increased risk of PSP. These findings expand our understanding of how the complex structure at 17q21.31 affect the risk of PSP. Key Points: Question: Do large copy number variations (i.e., α, β, and γ) inside 17q21.31 contribute to the risk of progressive supranuclear palsy (PSP) independently from the H1 and H2 haplotypes? Do structural forms of 17q21.31, characterized by combinations of α, β, and γ, present divergent risk to the development of PSP? Are structural forms of 17q21.31 associated with MAPT sub-haplotypes, such as H1c? Findings: In this case-control study of 1,684 individuals with PSP and 2,392 control subjects, the copy number of γ duplication was independently associated with the risk of the disease. H1 haplotypes with more γ duplications (H1β1γ2, H1β1γ3, and H1β1γ4) displayed a higher odds ratio for PSP when compared to H1β1γ1. Notably, H1β1γ3 was observed to be in linkage disequilibrium with H1c, a widely recognized MAPT sub-haplotype associated with PSP. Meaning: The association between the H1 and H2 haplotypes and PSP involves multiple contributing factors, including the copy number of γ duplication.


  • Open Access

    Noradrenaline release from the locus coeruleus shapes stress-induced hippocampal gene expression

    by Mattia Privitera, Lukas M. von Ziegler, Amalia Floriou-Servou, Sian N. Duss, Runzhong Zhang, Rebecca Waag, Sebastian Leimbacher, Oliver Sturman, Fabienne K. Roessler, Annelies Heylen, et al.

    Exposure to an acute stressor triggers a complex cascade of neurochemical events in the brain. However, deciphering their individual impact on stress-induced molecular changes remains a major challenge. Here we combine RNA-sequencing with selective pharmacological, chemogenetic and optogenetic manipulations to isolate the contribution of the locus coeruleus - noradrenaline (LC-NA) system to the acute stress response. We reveal that NA-release during stress exposure regulates a large and reproducible set of genes in the dorsal and ventral hippocampus via β-adrenergic receptors. For a smaller subset of these genes, we show that NA release triggered by LC stimulation is sufficient to mimic the stress-induced transcriptional response. We observe these effects in both sexes, and independent of the pattern and frequency of LC activation. Using a retrograde optogenetic approach, we demonstrate that hippocampus-projecting LC neurons directly regulate hippocampal gene expression. Overall, a highly selective set of astrocyte-enriched genes emerges as key targets of LC-NA activation, most prominently several subunits of protein phosphatase 1 (Ppp1r3c, Ppp1r3d, Ppp1r3g) and type II iodothyronine deiodinase (Dio2). These results highlight the importance of astrocytic energy metabolism and thyroid hormone signaling in LC-mediated hippocampal function and offer new molecular targets for understanding how NA impacts brain function in health and disease.